Medical Equipment

Intravenous (IV) Compounding Automation Market Analysis With Focus On Growth Potential And Future Outlook

May 7, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Anticipated Rise In Market Value Of The Intravenous (IV) Compounding Automation Market During The Forecast Period?

The intravenous (IV) compounding automation market has seen swift expansion in recent years. Its value is expected to rise from $2.19 billion in 2025 to $2.45 billion by 2026, achieving a compound annual growth rate (CAGR) of 11.9%. Historically, this growth can be attributed to several factors such as the increasing embrace of robotic compounding systems, a surging need for chemotherapy automation, a heightened focus on ensuring medication safety, the broadening application of automation in hospitals and pharmacies, and a growing recognition of the benefits of workflow efficiency.

The intravenous (IV) compounding automation market is set for substantial expansion in the upcoming years, with projections indicating it will reach $3.79 billion by 2030, growing at a compound annual growth rate (CAGR) of 11.6%. This projected growth throughout the forecast period stems from factors such as increasing investments in AI-enabled compounding solutions, the rising deployment of automated IV workstations, enhanced integration of software with hospital information systems, the expansion of remote monitoring and predictive maintenance capabilities, and the development of more modular and customizable compounding systems. Key trends anticipated during this period include breakthroughs in AI and machine learning for compounding, advancements in robotic and automated devices, the introduction of smart pump and monitoring technologies, innovations in sterile compounding isolators and safety cabinets, and the progress in compact and space-saving automation solutions.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30629&type=smp

What Key Factors Are Affecting The Intravenous (IV) Compounding Automation Market Demand?

The intravenous (IV) compounding automation market is expected to grow, propelled by the rising demand for pharmaceutical products. A pharmaceutical product refers to a substance or blend of substances created for diagnosing, treating, preventing, or relieving diseases and medical conditions in humans or animals. IV compounding automation enhances pharmaceutical product preparation by enabling the precise, safe, and efficient formulation of complex intravenous medications, ensuring exact dosing, reducing contamination risks, and allowing healthcare providers to fulfill the increasing need for high-quality therapies. For instance, in November 2023, according to the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based trade association, the total pharmaceutical production in Europe was €390,000 million ($422,803 million) in 2023, an increase from €363,300 million ($393,857 million) in 2022. Therefore, the escalating demand for pharmaceutical products is a primary force behind the growth of the intravenous (IV) compounding automation market.

Which Segments Define The Intravenous (IV) Compounding Automation Market Segment Structure?

The intravenous (iv) compounding automation market covered in this report is segmented –

1) By Product Type: Robotic Compounding Systems, Automated Compounding Devices, Software Solutions, Other Product Types

2) By Service: Installation, Maintenance, Training, Consulting, Support, System Integration, Validation, Software Updates, Calibration, Remote Monitoring

3) By Application: Chemotherapy, Parenteral Nutrition, Antibiotics, Other Applications

4) By End-User: Hospitals, Compounding Pharmacies, Oncology Centers, Other End-Users

Subsegments:

1) By Robotic Compounding Systems: Robotic Arm Based Systems, Closed System Robotic Compounding Units, Hazardous Drug Handling Robots, Sterile Preparation Robotic Platforms

2) By Automated Compounding Devices: Volumetric Compounding Devices, Gravimetric Compounding Devices, Multi Chamber Compounding Units, Automated Parenteral Nutrition Compounding Devices

3) By Software Solutions: Compounding Workflow Management Software, Dose Verification Software, Barcode Based Medication Safety Software, Compounding Data Analytics And Reporting Software

4) By Other Product Types: Semi Automated Compounding Systems, Isolator Based Compounding Systems, Sterile Admixture Preparation Cabinets, Hybrid Compounding Assistance Devices

Who Are The Established Players Within The Intravenous (IV) Compounding Automation Market?

Major companies operating in the intravenous (iv) compounding automation market are Becton Dickinson and Company, Baxter International Inc., Grifols S.A., ICU Medical Inc., Omnicell Inc., Fresenius Kabi AG, Equashield Medical Ltd., Health Robotics S.r.l., Loccioni Group, Loccioni Group, OPTIMA pharma GmbH, Medimix Systems AG, ARxIUM Inc., General Healthy Co. Ltd., PharmaScope Onco Automation B.V., Comecer SpA, Syntegon Technology GmbH, Parata Pharmacy Automation, B. Braun SE, Aesynt Incorporated, Shenzhen Broadcare Robots Co. Ltd.

Get The Full Intravenous (IV) Compounding Automation Market Report:

https://www.thebusinessresearchcompany.com/report/intravenous-iv-compounding-automation-market-report

Which Region Represents The Largest Share Of The Intravenous (IV) Compounding Automation Market?

North America was the largest region in the intravenous (IV) compounding automation market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intravenous (iv) compounding automation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Intravenous (IV) Compounding Automation Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=30629&type=smp

Browse Through More Reports Similar to the Global Intravenous (IV) Compounding Automation Market 2026, By The Business Research Company

Automated Compounding Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/automated-compounding-devices-global-market-report

Intravenous Solutions Market Report 2026

https://www.thebusinessresearchcompany.com/report/intravenous-solutions-global-market-report

lab automation in drug discovery global market report

https://www.thebusinessresearchcompany.com/report/lab-automation-in-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795